Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,017 | 326 | 99.6% |
| Education | $18.99 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $502.96 | 31 | $0 (2019) |
| Novo Nordisk Inc | $498.38 | 30 | $0 (2019) |
| Amgen Inc. | $452.36 | 26 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $392.58 | 32 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $369.93 | 25 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $327.16 | 18 | $0 (2019) |
| PFIZER INC. | $297.81 | 14 | $0 (2018) |
| Lilly USA, LLC | $269.66 | 20 | $0 (2019) |
| GlaxoSmithKline, LLC. | $252.62 | 14 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $220.37 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $33.68 | 2 | Regeneron Healthcare Solutions, Inc. ($18.99) |
| 2021 | $5.00 | 1 | Dynavax Technologies Corporation ($5.00) |
| 2019 | $870.38 | 53 | Novo Nordisk Inc ($150.72) |
| 2018 | $1,729 | 109 | Novo Nordisk Inc ($214.20) |
| 2017 | $2,398 | 162 | SANOFI-AVENTIS U.S. LLC ($346.03) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 4 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: UROLOGY | ||||||
| 10/10/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 09/27/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Endocrinology | ||||||
| 09/25/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: VACCINE | ||||||
| 09/12/2018 | Lilly USA, LLC | JARDIANCE (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 09/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 08/30/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: Diabetes | ||||||
| 08/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DIABETES | ||||||
| 08/22/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 08/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: KRYSTEXXA | ||||||
| 08/15/2018 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA, BREO | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Respiratory | ||||||
| 08/03/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 08/02/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: DIABETES | ||||||
| 07/25/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 07/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 07/12/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Pulmonology | ||||||
| 07/11/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,341 | 2,078 | $454,269 | $118,852 |
| 2022 | 16 | 1,515 | 2,294 | $470,032 | $125,696 |
| 2021 | 16 | 1,390 | 2,154 | $386,640 | $120,543 |
| 2020 | 19 | 1,535 | 2,097 | $338,874 | $146,423 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 510 | 1,205 | $333,908 | $49,923 | 15.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 317 | 317 | $54,207 | $42,682 | 78.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 112 | 113 | $8,778 | $7,906 | 90.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 174 | $34,278 | $4,891 | 14.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 21 | $6,510 | $4,675 | 71.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 120 | 121 | $5,445 | $3,900 | 71.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 23 | $5,934 | $3,861 | 65.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 68 | $2,788 | $737.40 | 26.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 15 | $510.00 | $200.85 | 39.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 19 | 21 | $1,911 | $77.21 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 523 | 1,263 | $338,081 | $52,288 | 15.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 275 | 275 | $47,025 | $37,782 | 80.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 143 | 143 | $10,000 | $9,726 | 97.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 159 | 159 | $7,155 | $5,058 | 70.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 172 | $32,286 | $4,840 | 15.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $3,840 | $3,575 | 93.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $4,340 | $3,195 | 73.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 16 | $4,128 | $2,654 | 64.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $3,934 | $2,503 | 63.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,345 | $1,488 | 27.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 53 | 56 | $2,296 | $654.68 | 28.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 35 | $4,010 | $634.15 | 15.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $663.00 | $544.67 | 82.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 64 | 68 | $6,188 | $325.60 | 5.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 11 | 11 | $236.00 | $228.72 | 96.9% |
About Dr. Christopher Badger, MD
Dr. Christopher Badger, MD is a Hospitalist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1477880094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Badger, MD has received a total of $5,036 in payments from pharmaceutical and medical device companies, with $33.68 received in 2023. These payments were reported across 327 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,017).
As a Medicare-enrolled provider, Badger has provided services to 5,781 Medicare beneficiaries, totaling 8,623 services with total Medicare billing of $511,514. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Baltimore, MD
- Active Since 11/04/2009
- Last Updated 04/25/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1477880094
Products in Payments
- TOUJEO (Drug) $293.55
- Prolia (Biological) $275.47
- ENTRESTO (Drug) $220.37
- JARDIANCE (Drug) $212.99
- FARXIGA (Drug) $204.64
- TRADJENTA (Drug) $201.07
- Victoza (Drug) $188.06
- Trintellix (Drug) $186.21
- JANUVIA (Drug) $173.81
- TRULICITY (Drug) $168.73
- ANORO (Drug) $161.79
- SOLIQUA (Drug) $153.14
- Ozempic (Drug) $148.26
- BEVESPI AEROSPHERE (Drug) $139.70
- XARELTO (Drug) $137.17
- ZOSTAVAX (Biological) $131.13
- XIFAXAN (Drug) $101.22
- CHANTIX (Drug) $98.25
- TRUMENBA (Biological) $91.80
- Tresiba (Drug) $90.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Baltimore
Eric Ritter, Md, MD
Hospitalist — Payments: $55,557
Francoise Marvel, Md, MD
Hospitalist — Payments: $47,167
Vu Duong, Md, MD
Hospitalist — Payments: $18,998
Mr. Felix Yelovich, Pa-C, PA-C
Hospitalist — Payments: $6,179
Ajay Hooda, M.d, M.D
Hospitalist — Payments: $5,967
Oneib Khan, Md, MD
Hospitalist — Payments: $4,777